Advertisement

Aclaris Therapeutics, Inc. ACRS

Set alert

Price alert · ACRS

All alert types
3.97 USD -0.02 -0.50%

At close

2.90 -1.07 -26.92%

Pre-market · Nov 2, 4:00 AM ET

Bid
3.96 × 2
Ask
3.97 × 2
3.87 Day range 4.07
2.10 52-week range 6.60
YTD
+31.89%
1 year
+59.44%
Open
4.02
Prev close
3.99
Mkt cap
615.29M
Vol
1.88M
Avg vol
2.91M
EPS
-0.58
P/E
0.00
Div yield
0.00%
More statistics
Low
3.87
High
4.07
Forward P/E
-5.00
Beta
0.12
Short ratio
0.47
Inst. own
90.21%
Dividend
0.00
Ex-div date
50-d avg
2.70
200-d avg
1.58
1y target
10.00

5D chart

Chart tools
Interval

Signals (76)
NameTimeAgo
SMA: BearishOct 30, 3:55 PM2 days ago
SMA: BullishOct 30, 3:50 PM2 days ago
MACD: Buy SignalOct 30, 3:35 PM2 days ago
SMA: BullishOct 30, 3:30 PM2 days ago
SMA: BearishOct 30, 2:10 PM2 days ago
MACD: Sell SignalOct 30, 1:30 PM2 days ago
SMA: BullishOct 30, 1:15 PM2 days ago
MACD: Buy SignalOct 30, 1:15 PM2 days ago
MACD: Sell SignalOct 30, 1:10 PM2 days ago
SMA: BullishOct 30, 11:55 AM2 days ago
MACD: Buy SignalOct 30, 11:55 AM2 days ago
MACD: Sell SignalOct 30, 11:45 AM2 days ago
SMA: BearishOct 30, 11:25 AM2 days ago
MACD: Buy SignalOct 30, 10:45 AM2 days ago
SMA: BullishOct 30, 10:35 AM2 days ago
SMA: BearishOct 30, 9:45 AM2 days ago
MACD: Sell SignalOct 30, 9:45 AM2 days ago
MACD: Buy SignalOct 29, 3:10 PM3 days ago
MACD: Sell SignalOct 29, 1:50 PM3 days ago
SMA: BullishOct 29, 1:15 PM3 days ago
SMA: BullishOct 29, 1:15 PM3 days ago
MACD: Buy SignalOct 29, 1:15 PM3 days ago
SMA: BearishOct 29, 1:10 PM3 days ago
SMA: BearishOct 29, 12:30 PM3 days ago
SMA: BearishOct 29, 11:40 AM3 days ago
SMA: BullishOct 29, 11:05 AM3 days ago
MACD: Sell SignalOct 29, 10:30 AM3 days ago
RSI: OverboughtOct 29, 10:15 AM3 days ago
RSI: OverboughtOct 28, 3:50 PM4 days ago
RSI: OverboughtOct 28, 3:30 PM4 days ago
MACD: Buy SignalOct 28, 2:40 PM4 days ago
SMA: BullishOct 28, 2:30 PM4 days ago
MACD: Sell SignalOct 28, 1:55 PM4 days ago
SMA: BullishOct 28, 12:40 PM4 days ago
MACD: Buy SignalOct 28, 12:40 PM4 days ago
SMA: BullishOct 28, 12:35 PM4 days ago
RSI: OversoldOct 28, 12:20 PM4 days ago
MACD: Sell SignalOct 28, 11:15 AM4 days ago
SMA: BearishOct 28, 11:05 AM4 days ago
SMA: BullishOct 28, 10:30 AM4 days ago
SMA: BearishOct 28, 10:20 AM4 days ago
SMA: BullishOct 28, 10:15 AM4 days ago
MACD: Buy SignalOct 28, 10:15 AM4 days ago
SMA: BullishOct 28, 10:05 AM4 days ago
SMA: BearishOct 28, 9:45 AM4 days ago
SMA: BearishOct 28, 9:45 AM4 days ago
SMA: BullishOct 28, 9:35 AM4 days ago
SMA: BullishOct 28, 9:35 AM4 days ago
SMA: BearishOct 27, 3:30 PM5 days ago
MACD: Sell SignalOct 27, 3:30 PM5 days ago
SMA: BearishOct 27, 3:25 PM5 days ago
MACD: Buy SignalOct 27, 2:55 PM5 days ago
SMA: BearishOct 27, 1:45 PM5 days ago
MACD: Sell SignalOct 27, 1:45 PM5 days ago
MACD: Buy SignalOct 27, 1:25 PM5 days ago
MACD: Sell SignalOct 27, 1:20 PM5 days ago
SMA: BullishOct 27, 1:05 PM5 days ago
MACD: Buy SignalOct 27, 1:05 PM5 days ago
MACD: Sell SignalOct 27, 1:00 PM5 days ago
SMA: BearishOct 27, 12:55 PM5 days ago
SMA: BullishOct 27, 11:15 AM5 days ago
SMA: BullishOct 27, 11:15 AM5 days ago
SMA: BearishOct 27, 11:05 AM5 days ago
MACD: Buy SignalOct 27, 10:30 AM5 days ago
SMA: BullishOct 27, 10:10 AM5 days ago
SMA: BearishOct 27, 9:30 AM5 days ago
MACD: Sell SignalOct 27, 9:30 AM5 days ago
RSI: OversoldOct 27, 9:30 AM5 days ago
MACD: Buy SignalOct 26, 3:40 PM6 days ago
SMA: BearishOct 26, 2:20 PM6 days ago
SMA: BearishOct 26, 2:20 PM6 days ago
MACD: Sell SignalOct 26, 2:10 PM6 days ago
MACD: Buy SignalOct 26, 2:05 PM6 days ago
MACD: Sell SignalOct 26, 12:50 PM6 days ago
SMA: BearishOct 26, 11:50 AM6 days ago
SMA: BearishOct 26, 10:20 AM6 days ago

Revenue & Expenses

Revenue by
Other Income → Expenses: $2.73MExpenses → Selling, General & Admin: $6.05MExpenses → Research & Development: $18.85MExpenses → Other Operating Expenses: $738.00KLicense and Service → Revenue: $1.27MGross Profit → Expenses: $1.40MRevenue → Gross Profit: $1.40MRevenue → Cost of Revenue: $231.00KContract research → Revenue: $356.00KNet Loss → Expenses: $21.50MOther Income$2.73MGross Profit$1.40MNet Loss$21.50MCost of Revenue$231.00KExpenses$25.64MSelling, General & Admin$6.05MResearch & Development$18.85MOther Operating Expenses$738.00KRevenue$1.63MLicense and Service$1.27MContract research$356.00K

Period ending Jun 30, 2026 · select a line to chart its history

Income statement

ACRS quarterly income statement
1.63M
1.63M
1.45M
176.00K
24.11M
18.07M
6.05M
-23.94M
-21.50M
-21.50M
-21.50M
-21.50M
-0.15
-0.15
-0.15
-21.50M
-21.50M
142.74M
142.74M

Balance sheet

ACRS quarterly balance sheet
19.17M
19.17M
151.45M
72.39M
79.06M
6.21M
97.77M
664.00K
179.69M
28.24M
55.11M
-1.01B
-304.00K
124.58M
124.58M
81.93M
18.29M
26.87M
15.52M

Cash flow

ACRS quarterly cash flow
107.00K
91.00K
-9.49M
-58.00K
114.00K
10.26M
10.32M
-19.85M
2.67M
Advertisement